TABLE OF CONTENTS

1. INTRODUCTION 24
1.1. OBJECTIVES OF THE STUDY 24
1.2. MARKET DEFINITION 24
1.3. OVERVIEW OF GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET 25
1.4. CURRENCY AND PRICING 26
1.5. LIMITATION 26
1.6. MARKETS COVERED 27
2. MARKET SEGMENTATION 29
2.1. MARKETS COVERED 29
2.2. GEOGRAPHIC SCOPE 29
2.3. YEARS CONSIDERED FOR THE STUDY 31
2.4. CURRENCY AND PRICING 31
2.5. RESEARCH METHODOLOGY 32
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.7. SECONDARY SOURCES 37
2.8. ASSUMPTIONS 37
3. MARKET OVERVIEW 38
3.1. DRIVERS 40
3.1.1. RISING AGING AND GERIATRIC POPULATION 40
3.1.2. TECHNOLOGICAL ADVANCEMENT IN NEGATIVE PRESSURE WOUND THERAPY DEVICES 40
3.1.3. INCREASED NUMBER OF SURGICAL PROCEDURES 41
3.1.4. GOVERNMENT SUPPORT FOR PROMOTING NEGATIVE PRESSURE WOUND THERAPY 41
3.1.5. RISING INCIDENCE OF DIABETES 42
?
3.2. RESTRAINTS 43
3.2.1. HIGH COST OF PRODUCTS 43
3.2.2. AVAILABILITY OF SUBSTITUTE PRODUCTS 43
3.2.3. COMPLICATIONS ASSOCIATED WITH THE USAGE OF NPWT SYSTEMS 44
3.3. OPPORTUNITIES 45
3.3.1. FAVORABLE REIMBURSEMENT SCENARIO 45
3.3.2. MERGERS AND ACQUISITION BY KEY PLAYERS 45
3.4. CHALLENGES 46
3.4.1. LACK OF SKILLED PROFESSIONALS 46
4. EXECUTIVE SUMMARY 47
5. PREMIUM INSIGHTS 50
6. GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET,
BY PRODUCT TYPE 53
6.1. OVERVIEW 54
6.2. STAND-ALONE NEGATIVE PRESSURE WOUND THERAPY DEVICES 56
6.3. PORTABLE NEGATIVE PRESSURE WOUND THERAPY DEVICES 57
6.4. DISPOSABLE NEGATIVE PRESSURE WOUND THERAPY DEVICES 58
7. GLOBAL NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY END-USER 59
7.1. OVERVIEW 60
7.2. HOSPITALS 62
7.3. WOUND CARE CENTER 63
7.4. AMBULATORY CENTERS 64
7.5. HOME HEALTHCARE 65
7.6. CLINICS 66
7.7. COMMUNITY HEALTHCARE 67
?
8. GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET,
BY WOUND TYPE 68
8.1. OVERVIEW 69
8.2. SURGICAL WOUND 71
8.3. DIABETIC ULCERS 72
8.4. BURN 73
8.5. PRESSURE ULCERS 74
8.6. VENOUS ULCERS 75
8.7. OTHERS 76
9. GLOBAL NEGATIVE PRESSURE WOUND THERAPY MARKET,
BY DISTRIBUTION CHANNEL 77
9.1. OVERVIEW 78
9.2. DIRECT TENDERS 80
9.3. RETAIL 81
10. GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET,
BY GEOGRAPHY 82
10.1. OVERVIEW 83
10.2. NORTH AMERICA 90
10.2.1. U.S. 99
10.2.2. CANADA 102
10.2.3. MEXICO 105
10.3. EUROPE 108
10.3.1. GERMANY 118
10.3.2. FRANCE 121
10.3.3. U.K. 124
10.3.4. ITALY 127
10.3.5. SPAIN 130
10.3.6. RUSSIA 133
10.3.7. TURKEY 136
10.3.8. BELGIUM 139
10.3.9. NETHERLANDS 142
10.3.10. SWITZERLAND 145
10.3.11. REST OF EUROPE 148
10.4. ASIA-PACIFIC 149
10.4.1. JAPAN 160
10.4.2. CHINA 163
10.4.3. SOUTH KOREA 166
10.4.4. INDIA 169
10.4.5. AUSTRALIA 172
10.4.6. SINGAPORE 175
10.4.7. THAILAND 178
10.4.8. MALAYSIA 181
10.4.9. INDONESIA 184
10.4.10. PHILIPPINES 187
10.4.11. REST OF ASIA-PACIFIC 190
10.5. SOUTH AMERICA 191
10.5.1. BRAZIL 200
10.5.2. REST OF SOUTH AMERICA 203
10.6. MIDDLE EAST AND AFRICA 204
10.6.1. SOUTH AFRICA 213
10.6.2. SAUDI ARABIA 216
10.6.3. UAE 219
10.6.4. REST OF MIDDLE EAST AND AFRICA 222
11. GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, COMPANY LANDSCAPE 223
11.1. COMPANY SHARE ANALYSIS; GLOBAL 223
11.2. COMPANY SHARE ANALYSIS; NORTH AMERICA 224
11.3. COMPANY SHARE ANALYSIS; EUROPE 225
11.4. COMPANY SHARE ANALYSIS; ASIA-PACIFIC 226
12. COMPANY PROFILE 227
12.1. ACELITY L.P. INC. 227
12.1.1. COMPANY OVERVIEW 227
12.1.2. REVENUE ANALYSIS 227
12.1.3. PRODUCT PORTFOLIO 228
12.1.4. RECENT DEVELOPMENTS 228
12.2. SMITH AND NEPHEW 229
12.2.1. COMPANY OVERVIEW 229
12.2.2. REVENUE ANALYSIS 229
12.2.3. PRODUCT PORTFOLIO 230
12.2.4. RECENT DEVELOPMENTS 230
12.3. MOLNLYCKE HEALTHCARE 231
12.3.1. COMPANY OVERVIEW 231
12.3.2. COMPANY SNAPSHOT 231
12.3.3. PRODUCT PORTFOLIO 232
12.3.4. RECENT DEVELOPMENTS 232
12.4. CONVATEC INC. 233
12.4.1. COMPANY OVERVIEW 233
12.4.2. REVENUE ANALYSIS 233
12.4.3. PRODUCT PORTFOLIO 234
12.4.4. RECENT DEVELOPMENTS 234
12.5. CARDINAL HEALTH 235
12.5.1. COMPANY OVERVIEW 235
12.5.2. REVENUE ANALYSIS 235
12.5.3. PRODUCT PORTFOLIO 236
12.5.4. RECENT DEVELOPMENTS 236
?
12.6. MEDELA (OLLE LARSSON HOLDING AG) 237
12.6.1. COMPANY OVERVIEW 237
12.6.2. COMPANY SNAPSHOT 237
12.6.3. PRODUCT PORTFOLIO 238
12.6.4. RECENT DEVELOPMENTS 238
12.7. WOUND RX MEDICAL, LLC 239
12.7.1. COMPANY OVERVIEW 239
12.7.2. COMPANY SNAPSHOT 239
12.7.3. PRODUCT PORTFOLIO 239
12.7.4. RECENT DEVELOPMENTS 240
12.8. PAUL HARTMANN LIMITED 241
12.8.1. COMPANY OVERVIEW 241
12.8.2. COMPANY SNAPSHOT 241
12.8.3. PRODUCT PORTFOLIO 242
12.8.4. RECENT DEVELOPMENTS 242
12.9. TALLY GROUP LIMITED 243
12.9.1. COMPANY OVERVIEW 243
12.9.2. COMPANY SNAPSHOT 243
12.9.3. PRODUCT PORTFOLIO 243
12.9.4. RECENT DEVELOPMENTS 243
12.10. TRIAGE MEDITECH PVT. LTD. 244
12.10.1. COMPANY OVERVIEW 244
12.10.2. COMPANY SNAPSHOT 244
12.10.3. PRODUCT PORTFOLIO 245
12.10.4. RECENT DEVELOPMENTS 245
13. RELATED REPORTS 246